bradley mcgregor, md, on combo ipilimumab nivolumab in variant histologies of bladder cancer
Published 5 years ago • 42 plays • Length 1:29
Download video MP4
Download video MP3
Similar videos
-
1:49
bradley mcgregor, md, discusses checkmate-214 investigating nivolumab ipilimumab in rcc patients
-
1:56
nivolumab and ipilimumab for advanced bcvh
-
1:16
bradley mcgregor, md, on the data regarding enfortumab in post-platinum i-o bladder cancer
-
1:13
bradley mcgregor, md, on mrcc patients whose cancer returns and were previously treated with i-o
-
1:19
bradley mcgregor, md, on impressions of the oral inhibitor study in renal cell carcinoma patients
-
1:01
bradley mcgregor, md, describes if biomarkers help guide treatment in advanced renal cell carcinoma
-
1:49
dr. mcgregor on immunotherapy combinations in kidney cancer
-
0:53
dr. rosenberg on dosing of nivolumab plus ipilimumab in bladder cancer
-
1:32
bradley mcgregor, md, shares presented data investigating atezolizumab and cabozantinib in mcrpc
-
1:47
dr. mcgregor on choosing a combination therapy regimen in advanced rcc
-
0:52
bert o'neil, md and the combination of ipilimumab with nivolumab in mcrc patients
-
1:18
bradley mcgregor, md, considers strategies for treating 2nd line rcc patients
-
2:09
bradley mcgregor, md, considers the optimal approach to treating newly diagnosed rcc patients
-
0:53
philip philip, md on the importance of ipilimumab prior to nivolumab in mcrc patients
-
1:54
dr. mcgregor on immunotherapy in rare genitourinary cancers
-
2:09
checkmate 032: nivolumab/ipilimumab for urothelial carcinoma
-
1:05
nivolumab and ipilimumab combination in frontline mcrc
-
1:03
dr. mcgregor on the evolving treatment landscape of rcc
-
1:08
dr. motzer on nivolumab/ipilimumab activity in rcc
Clip.africa.com - Privacy-policy